Table 2 Metabolites found to be significant between vehicle-injected Ptn-Tg mice and vehicle-injected Wt mice.
Feature | P-value | % VAR (Ptn-Tg vs Wt) | Name | Polarity | Adduct |
|---|---|---|---|---|---|
0.0004 | − 37.6 | 3-Hydroxy-2-methylpyridine-4,5-dicarboxylate | POS | M+H | |
0.0076 | − 33.2 | Aspartic acid | POS | M+H | |
0.0120 | − 28.7 | 5-Oxo-d-proline/d-pyroglutamic acid/d-5-pyrrolidone-2-carboxylic acid | POS | M+H | |
0.0360 | − 16.5 | 1,2-Diamino-4-nitrobenzene/N-dimethyl-2-aminoethylphosphonate; 2-dimethylaminoethylphosphonate | POS | M+H | |
0.0360 | − 36.6 | Ser Ala Cys | POS | M+H | |
0.0256 | 75.2 | Bis (2-hydroxypropyl) amine | POS | M+H | |
0.0016 | − 45.9 | Methylnoradrenaline/epinephrine/normetanephrine | POS | M+H | |
0.0256 | − 49.4 | Dihydrozeatin | POS | M+H | |
0.0028 | − 39.7 | Methylmalonic acid semialdehyde/2-methyl-3-oxo-propanoic acid/3-methyl pyruvic acid/Acetoacetic acid | POS | M+H | |
0.0076 | 39.4 | ent-9-L1-PhytoP | POS | M+H | |
0.0076 | 57.0 | d-erythro-sphingosine C-15 | POS | M+H | |
0.0120 | 105.9 | N-Linoleoyl GABA/N-cis-octadec-9Z-enoyl-l-homoserine lactone | POS | M+H | |
0.0004 | − 45.1 | Retinol | POS | M+H | |
0.0176 | 43.4 | (24Z),26-hydroxydesmosterol | POS | M+H | |
0.0496 | 28.8 | Stoloniferone G | POS | M+H | |
0.0048 | − 26.6 | l-carnitine | POS | M+H | |
0.0360 | − 39.5 | Tetradecanoylcarnitine | POS | M+H | |
0.0028 | − 51.9 | O-palmitoleoylcarnitine | POS | M+H | |
0.0016 | − 40.2 | O-arachidonoylcarnitine | POS | M+H | |
0.0256 | − 46.2 | O-oleoylcarnitine/elaidic carnitine | POS | M+H | |
0.0176 | − 44.6 | Neuraminic acid/deoxyguanosine/adenosine | NEG | M−H | |
0.0360 | − 34.8 | Axillarenic acid/tetracosanedioic acid | POS | M+H | |
0.0496 | − 34.8 | Amino-octadecanoic acid | POS | M+H | |
0.0004 | − 47.0 | Norchenodeoxycholic acid | POS | M+H | |
0.0016 | − 40.6 | 10-oxo-nonadecanoic acid | POS | M+H | |
0.0004 | − 55.3 | 2-oxo-heneicosanoic acid | POS | M+H | |
0.0004 | − 46.9 | Glycidyl oleate | POS | M+H | |
0.0360 | − 41.8 | Amphimic acid B | POS | M+H | |
0.0120 | 55.4 | DG(43:5) | POS | M+H | |
0.0360 | − 21.9 | DG(38:6) | POS | M+H | |
0.0028 | − 44.6 | DG(38:7) | POS | M+H | |
0.0004 | − 39.2 | DG(36:4) | POS | M+H | |
0.0004 | − 49.0 | DG(38:5) | POS | M+H | |
0.0004 | − 44.5 | DG(38:4) | POS | M+H | |
0.0256 | − 29.9 | DG(38:4) | POS | M+H | |
0.0120 | 14.0 | PC(35:6) | POS | M+H | |
0.0360 | − 27.4 | PC(37:4) | POS | M+H | |
0.0028 | − 12.5 | PC(38:4) | POS | M+H | |
0.0360 | − 31.2 | PC(35:1) | POS | M+H | |
0.0496 | − 15.2 | PC(38:2) | POS | M+H | |
0.0076 | − 37.5 | PE-NMe(11D5/13M5) | NEG | M−H | |
0.0120 | 68.9 | PG(37:0) | NEG | M−H | |
0.0004 | 55.5 | PGP(38:0) | POS | M+H | |
0.0028 | 135.6 | SM(36:2) | POS | M+H | |
0.0120 | 70.1 | SM(36:1) | POS | M+H | |
0.0076 | 60.6 | SM(37:1)/PE-Cer(40:1) | POS | M+H | |
0.0360 | 155.4 | PI(38:6) | NEG | M−H | |
0.0256 | 60.3 | PI(36:4) | NEG | M−H | |
0.0120 | 133.0 | PI(38:5) | NEG | M−H | |
0.0120 | 45.6 | PI(38:4) | NEG | M−H | |
0.0028 | 59.6 | PI(44:12) | NEG | M−H | |
0.0496 | − 26.9 | GlcCer(42:1) | NEG | M−H | |
0.0256 | − 48.7 | GlcCer(42:0) | NEG | M−H | |
0.0028 | − 61.5 | Ganglioside GM3 (36:1) | NEG | M−H |
